Product Information
LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0750 per EA under NDC 68180021606. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on May 21, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 100 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180021606
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078245FDA Approved
5/21/2010
TE Code
AB
On Market Since
10/6/2010
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 40.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0750 per EA |
|---|---|
| All-time high | $0.2088 (Apr 13, 2022) |
| All-time low | $0.0742 (Jul 22, 2026) |
| 52-week high | $0.0973 |
| 52-week low | $0.0742 |
| Median price | $0.1190 |
| Average price | $0.1207 |
| Largest weekly change | +42.6% (Dec 18, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.0750 per EA (NDC 68180021606), effective Aug 19, 2026.
How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has declined 40.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has ranged from a low of $0.0742 (Jul 22, 2026) to a high of $0.2088 (Apr 13, 2022), with a median of $0.1190 per EA.
Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB (NDC 68180021606) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.